Inmunología, Oftalmología y ORL
Department
University Hospital Heidelberg
Heidelberg, AlemaniaPublications in collaboration with researchers from University Hospital Heidelberg (5)
2024
-
Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation
Blood, Vol. 143, Núm. 10, pp. 872-881
2023
-
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)
Leukemia
-
JNKs protect from cholestatic liver disease progression by modulating Apelin signalling
JHEP Reports, Vol. 5, Núm. 11
2019
-
Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
Gut, Vol. 68, Núm. 8, pp. 1477-1492
2018
-
Prospective Evaluation of Two iStent ® Trabecular Stents, One iStent Supra ® Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Advances in Therapy, Vol. 35, Núm. 3, pp. 395-407